Boji Pharmaceutical (300404): 2021 Independent Director Debriefing Report (Hao Yingqi) CFi.CN

  • Post date April 26, 2022 — 15:04 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002340 300404 300568 300713 China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Gem Guangzhou Boji Medical & Biotechnological Shenzhen Senior Technology Material Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Arts, Culture, Entertainment, Media Crime, Law, Justice Law Regulations Accounting, Audit Management Stock Option Annual, Special Corporate Meeting Annual Report Board Of Directors Research, Development Pharmaceutical Construction, Property Electricity Production, Distribution Media Market, Exchange Securities Diseases, Conditions Medicine Records, Achievements Occupation Small, Medium Enterprise Economy, Business, Finance Education Environment

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data